The sigma ligand SR 31747 prevents the development of acute graft-versus-host disease in mice by blocking IFN-γ and GM-CSF mRNA expression
- 1 September 1995
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 17 (9) , 753-761
- https://doi.org/10.1016/0192-0561(95)00066-b
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cytokine gene expression in mice undergoing chronic graft-versus-host diseaseMolecular Immunology, 1993
- Differential cytokine expression in acute and chronic murine graft‐versus‐host‐diseaseEuropean Journal of Immunology, 1993
- Pharmacologic manipulation of graft versus host induced splenomegalyInflammation Research, 1992
- Diversity of Cytokine Synthesis and Function of Mouse CD4+ T CellsImmunological Reviews, 1991
- A study of cytokine production in acute graft-vs-host diseaseCellular Immunology, 1991
- Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon-γThe Lancet, 1990
- Lymphokine gene expression in vivo is inhibited by cyclosporin A.The Journal of Experimental Medicine, 1990
- In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon.The Journal of Experimental Medicine, 1987
- Graft-versus-host induced immunosuppression: Depressed T cell helper function in vitroCellular Immunology, 1976
- Cellular Immunology and the Pathogenesis of Graft Versus Host Reactions (Part 1 of 3)Published by S. Karger AG ,1971